• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2722-9
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 11/14/2025
Type of Reportable Event Malfunction
Event or Problem Description
A user facility registered nurse (rn) reported that a combi set blood leak occurred during a patient¿s hemodialysis (hd) treatment.Additional details were provided upon follow-up with a charge nurse (cn) from the facility.The cn stated the blood leak occurred approximately two hours into the treatment.The machine, a fresenius 2008t machine, was alarming with an air detector message.When they inspected the setup, they noticed there was air in the venous chamber, and blood was leaking from the combi set.Upon further inspection, they noticed there was a small hole in the blood pump tubing.The blood leak was coming from the small hole, and it was determined that the air had entered the circuit at the hole.After the leak was identified, the treatment was stopped.The patient¿s blood was not returned; estimated blood loss (ebl) was 300 ml.The cn confirmed there was no patient serious injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.The sample was not available to be returned for manufacturer evaluation as it was reportedly discarded.
 
Additional Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Additional Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the facility for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius combi sets shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Event or Problem Description
A user facility registered nurse (rn) reported that a combi set blood leak occurred during a patient¿s hemodialysis (hd) treatment.Additional details were provided upon follow-up with a charge nurse (cn) from the facility.The cn stated the blood leak occurred approximately two hours into the treatment.The machine, a fresenius 2008t machine, was alarming with an air detector message.When they inspected the setup, they noticed there was air in the venous chamber, and blood was leaking from the combi set.Upon further inspection, they noticed there was a small hole in the blood pump tubing.The blood leak was coming from the small hole, and it was determined that the air had entered the circuit at the hole.After the leak was identified, the treatment was stopped.The patient¿s blood was not returned; estimated blood loss (ebl) was 300 ml.The cn confirmed there was no patient serious injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.The sample was not available to be returned for manufacturer evaluation as it was reportedly discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Common Device Name
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
900 w zaragosa drive suite d
pharr TX 78577
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key23688793
Report Number0008030665-2025-02892
Device Sequence Number9521061
Product Code FJK
UDI-Device Identifier00840861100293
UDI-Public00840861100293
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K962081
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 03/25/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03-2722-9
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/15/2025
Supplement Date Received by Manufacturer03/20/2026
Initial Report FDA Received Date12/01/2025
Supplement Report FDA Received Date03/25/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FRESENIUS 2008T MACHINE.; FRESENIUS 2008T MACHINE.; FRESENIUS OPTIFLUX DIALYZER.; FRESENIUS OPTIFLUX DIALYZER.
Patient Age55 YR
Patient SexMale
Patient Weight108 KG
-
-